Therapeutic Asset Ratings
5,108 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Daraxonrasib
Pancreatic Adenocarcinoma
Revolution Medicines, Inc.
P3
BB
(66)
Daraxonrasib
Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
P3
BB
(66)
Darolutamide
Prostate Adenocarcinoma
Region Stockholm
P3
BB
(66)
Dasatinib
Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(66)
Daunorubicin
Down Syndrome
National Hospital Organization Nagoya Medical Center
P3
BB
(66)
Daunorubicin
Myeloid Sarcoma
Kura Oncology, Inc.
P3
BB
(66)
Daunorubicin
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(66)
Daunorubicin
T-Lymphoblastic Lymphoma
Children's Oncology Group
P3
BB
(66)
Decitabine
Acute Monocytic Leukemia
Roswell Park Cancer Institute
P3
BB
(66)
Decitabine
Adult Acute Monocytic Leukemia
Roswell Park Cancer Institute
P3
BB
(66)
Decitabine
Acute Myeloblastic Leukemia Without Maturation
Roswell Park Cancer Institute
P3
BB
(66)
Decitabine
Acute Myelomonocytic Leukemia M4
Roswell Park Cancer Institute
P3
BB
(66)
Denifanstat
Metabolic Dysfunction-Associated Steatotic Liver Disease
Sagimet Biosciences Inc.
P3
BB
(66)
DEXAMETHASONE
AL Amyloidosis
St. Olavs Hospital
P3
BB
(66)
DEXAMETHASONE
Down Syndrome
National Cancer Institute (NCI)
P3
BB
(66)
DEXAMETHASONE
Metastatic Malignant Neoplasm
Genmab
P3
BB
(66)
DEXAMETHASONE
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche
P3
BB
(66)
DEXAMETHASONE
Neoplasm
Hellenic Society of Hematology
P3
BB
(66)
DEXAMETHASONE
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research Hospital
P3
BB
(66)
Divozilimab
Multiple Sclerosis
Biocad
P3
BB
(66)
Docetaxel
Malignant Pancreatic Neoplasm
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
P3
BB
(66)
Docetaxel
Gastroesophageal Junction Adenocarcinoma
Kyowa Kirin Co., Ltd.
P3
BB
(66)
Docetaxel
Ovarian Carcinoma
Case Comprehensive Cancer Center
P3
BB
(66)
Docetaxel
Urothelial Carcinoma
NuCana plc
P3
BB
(66)
DOXORUBICIN
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(66)
Showing 1101 to 1125 of 5,108 assets
Previous
Page 45 of 205
Next